C11ORF84 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62880819942757E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.87683202312883E-12 |
Normal-vs-Stage2 |
2.953800E-04 |
Normal-vs-Stage3 |
1.83810000553564E-09 |
Normal-vs-Stage4 |
3.41140000026385E-07 |
Stage1-vs-Stage2 |
1.973960E-01 |
Stage1-vs-Stage3 |
9.970400E-01 |
Stage1-vs-Stage4 |
2.905400E-01 |
Stage2-vs-Stage3 |
2.508800E-01 |
Stage2-vs-Stage4 |
7.013700E-02 |
Stage3-vs-Stage4 |
3.282400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.04747330201371E-12 |
Normal-vs-AfricanAmerican |
8.81189998747089E-09 |
Normal-vs-Asian |
1.01999997337288E-09 |
Caucasian-vs-AfricanAmerican |
4.603400E-03 |
Caucasian-vs-Asian |
1.211690E-02 |
AfricanAmerican-vs-Asian |
4.274600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.93485285757833E-12 |
Normal-vs-Female |
2.77555756156289E-15 |
Male-vs-Female |
2.373800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.51525999999569E-05 |
Normal-vs-Age(41-60Yrs) |
9.68114477473137E-14 |
Normal-vs-Age(61-80Yrs) |
2.14710027535148E-10 |
Normal-vs-Age(81-100Yrs) |
6.059900E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.736640E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.605800E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.106200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.302390E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.028000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.719600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.14269995874639E-09 |
Normal-vs-Grade 2 |
5.38635802627141E-12 |
Normal-vs-Grade 3 |
1.01249999495678E-08 |
Normal-vs-Grade 4 |
1.05810027406505E-10 |
Grade 1-vs-Grade 2 |
7.571800E-02 |
Grade 1-vs-Grade 3 |
6.366000E-02 |
Grade 1-vs-Grade 4 |
7.322200E-01 |
Grade 2-vs-Grade 3 |
3.811800E-01 |
Grade 2-vs-Grade 4 |
1.880910E-03 |
Grade 3-vs-Grade 4 |
5.008900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.47719999957319E-07 |
Normal-vs-ccB subtype |
2.19824158875781E-13 |
ccA subtype-vs-ccB subtype |
1.564410E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.80570028216221E-11 |
Normal-vs-N1 |
4.200800E-04 |
N0-vs-N1 |
2.205200E-01 |
|
|